It improves the skin and body health
Both assumptions are wrong, and the difference matters before a single injection is prescribed
(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
Higher-intensity options like cycling, swimming, or interval training can be incorporated as fitness improves
Recommended diluent: Bacteriostatic Water (BAC water) with 0.9% benzyl alcohol preservative
Several animal studies and preliminary human trials have suggested that allulose may influence postprandial glucose responses and potentially affect GLP-1 secretion, though the evidence base remains limited and requires further validation